Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07SPG
|
|||
| Former ID |
DIB009362
|
|||
| Drug Name |
ARGX-110
|
|||
| Synonyms |
ARGX-110 program, arGEN-X BV; Human mAb (SIMPLE antibody, autoimmune disease/inflammatory disease/cancer), arGEN-X
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Company |
ArGEN-X BV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01813539) Phase 1b Study of ARGX-110 in Patients With Advanced Malignancies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.